T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fortinet
FTNT
|
+$2.09B |
| 2 |
Rockwell Automation
ROK
|
+$1.46B |
| 3 |
Autodesk
ADSK
|
+$1.19B |
| 4 |
Citigroup
C
|
+$1.11B |
| 5 |
ConocoPhillips
COP
|
+$1.08B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.23B |
| 2 |
GE Aerospace
GE
|
+$2.12B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.46B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.17B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| 1 | Technology | 32.25% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Akebia Therapeutics
AKBA
$830M
| $110K | ﹤0.01% |
59,900
| – | – |
|
2752
Advantage Solutions
ADV
$626M
| $109K | ﹤0.01% |
25,007
+4,584
| +22% | +$20K |
|
2753
Daktronics
DAKT
$856M
| $109K | ﹤0.01% |
+10,923
| New | +$109K |
|
2754
Definitive Healthcare
DH
$432M
| $109K | ﹤0.01% |
13,391
+1,387
| +12% | +$11.3K |
|
|
INZY
2755
DELISTED
Inozyme Pharma
INZY
| $109K | ﹤0.01% |
14,222
+1,526
| +12% | +$11.7K |
|
|
OSG
2756
DELISTED
Overseas Shipholding Group Inc.
OSG
| $109K | ﹤0.01% |
17,020
+1,162
| +7% | +$7.44K |
|
2757
Comtech Telecommunications
CMTL
$69.7M
| $107K | ﹤0.01% |
30,997
+2,042
| +7% | +$7.05K |
|
2758
P10
PX
$1.35B
| $107K | ﹤0.01% |
12,608
+1,747
| +16% | +$14.8K |
|
2759
Farmer Brothers
FARM
$42.9M
| $106K | ﹤0.01% |
29,600
| – | – |
|
2760
MaxCyte
MXCT
$150M
| $106K | ﹤0.01% |
25,199
+4,320
| +21% | +$18.2K |
|
2761
NuScale Power
SMR
$4.73B
| $106K | ﹤0.01% |
19,729
+4,014
| +26% | +$21.6K |
|
2762
Purple Innovation
PRPL
$118M
| $105K | ﹤0.01% |
60,009
+20,400
| +52% | +$35.7K |
|
2763
Vuzix
VUZI
$178M
| $105K | ﹤0.01% |
86,380
-3,710
| -4% | -$4.51K |
|
2764
Petco
WOOF
$1.06B
| $104K | ﹤0.01% |
45,290
+4,836
| +12% | +$11.1K |
|
2765
Applied Digital
APLD
$3.98B
| $103K | ﹤0.01% |
24,018
+3,182
| +15% | +$13.6K |
|
|
VXRT
2766
DELISTED
Vaxart
VXRT
| $103K | ﹤0.01% |
78,500
| – | – |
|
2767
Innodata
INOD
$1.71B
| $102K | ﹤0.01% |
15,348
+982
| +7% | +$6.53K |
|
2768
Sutro Biopharma
STRO
$83.3M
| $102K | ﹤0.01% |
18,027
+3,578
| +25% | +$20.2K |
|
2769
Tango Therapeutics
TNGX
$758M
| $102K | ﹤0.01% |
12,771
+1,426
| +13% | +$11.4K |
|
|
ENFN
2770
DELISTED
Enfusion, Inc.
ENFN
| $102K | ﹤0.01% |
+11,013
| New | +$102K |
|
2771
Fossil Group
FOSL
$160M
| $102K | ﹤0.01% |
99,488
+49,100
| +97% | +$50.3K |
|
2772
GoodRx Holdings
GDRX
$1.43B
| $102K | ﹤0.01% |
14,300
| – | – |
|
|
TPIC
2773
DELISTED
TPI Composites
TPIC
| $100K | ﹤0.01% |
34,347
+3,737
| +12% | +$10.9K |
|
|
NXDR
2774
Nextdoor Holdings
NXDR
$778M
| $99K | ﹤0.01% |
43,779
+9,689
| +28% | +$21.9K |
|
2775
Energy Vault
NRGV
$312M
| $99K | ﹤0.01% |
54,933
+7,930
| +17% | +$14.3K |
|